Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Open-market sale EVP, CBO, GC & Secretary sold 26,500 shares at an average $25.37 ($672,279)
  2. 4 Open-market sale Director sold 5,000 shares at $23.50 ($117,500)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale EVP, Chief Medical Officer sold 1,375 shares at $16.48 ($22,663)
  5. 4 Open-market sale Chief Dev Operations Officer sold 2,975 shares at $16.48 ($49,034)
  6. 4 Open-market sale EVP, CBO, GC & Secretary sold 2,961 shares at $16.48 ($48,803)
  7. 4 Open-market sale President & CSO sold 17,634 shares at $16.48 ($290,642)
  8. 4 Open-market sale Chief Executive Officer sold 17,634 shares at $16.48 ($290,642)
  9. 4 Exercise or conversion EVP, Chief Medical Officer acquired 4,850 shares (option exercise)
  10. 4 Exercise or conversion Chief Dev Operations Officer acquired 9,675 shares (option exercise)
  11. 4 Exercise or conversion EVP, CBO, GC & Secretary acquired 9,675 shares (option exercise)
  12. 4 Exercise or conversion President & CSO acquired 43,600 shares (option exercise)
  13. 4 Exercise or conversion Chief Executive Officer acquired 43,600 shares (option exercise)
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 16 of 31 · 601 filings